Related Experiment Video
Updated: Jul 15, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
[Testing for Mycoplasma pneumonia using the ImmunoCard Mycoplasma rapid test]
Niro Okimoto1, Takashi Kibayashi, Michihiro Kishimoto
1Center of Respiratory Diseases, Kawasaki Medical School, Kawasaki Hospital.
Abstract:
We evaluated the effectiveness of ImmunoCard Mycoplasma rapid tests in all patients admitted with community-acquired pneumonia (CAP) between January, 2004 and December, 2005. ImmunoCard Mycoplasma rapid tests were performed on the 1st day of admission and we analyzed the frequency of positive cases among CAP cases according to month and age. A total of 82 of 270 (33.7%) and 41 of 257 (16.0%) were positive among CAP cases in 2004 and 2005, respectively. More positive cases were seen between spring and early summer and in cases aged 70 years or more, especially those over 80 years old. These results indicated that further evaluation is required among positive cases in elder group.
Insights
The ImmunoCard Mycoplasma rapid test showed varying effectiveness in diagnosing community-acquired pneumonia (CAP). Positive results were more frequent in spring/summer and in elderly patients over 70.
Area of Science:
- Medical diagnostics
- Infectious disease research
- Respiratory medicine
Context:
- Community-acquired pneumonia (CAP) presents a significant public health challenge.
- Rapid diagnostic tests are crucial for timely and effective CAP management.
- Evaluating diagnostic tool efficacy in real-world clinical settings is essential.
Purpose:
- To assess the effectiveness of the ImmunoCard Mycoplasma rapid test for diagnosing CAP.
- To analyze the frequency of Mycoplasma-positive CAP cases based on month and age.
- To identify demographic groups with higher Mycoplasma prevalence in CAP.
Summary:
- The study evaluated ImmunoCard Mycoplasma rapid tests in CAP patients from 2004-2005.
- Positive rates were 33.7% in 2004 and 16.0% in 2005.
- Higher positivity was observed in spring/early summer and in patients aged 70+, particularly those over 80.
Impact:
- Highlights the need for targeted Mycoplasma testing in specific age groups.
- Suggests seasonal variations in Mycoplasma-related CAP.
- Indicates potential for improved diagnostic strategies in elderly CAP patients.
More Related Videos
Related Concept Videos
Rapid Identification of Pathogens
Automated Microbial Diagnostics
Pneumonia III: Complications and Assessment
